FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
This brief was updated in November 2024 to reflect CMS’s final guidance for the second year of the drug price negotiation program. The Inflation Reduction Act of 2022 (the Act), signed into law by President Biden in August 2022, includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by … Read more